Elevated cAMP levels reverse Brucella melitensis-induced lipid peroxidation and stimulate IL-10 transcription in rats

Research in Veterinary Science

Volumn 82, Issue 2, 2007, Pages 181-186

  Erdogan, S ^a   Celik, S ^a   Aslantas, O ^a   Kontas, T ^a   Ocak, S ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Brucella melitensis; cAMP; Cytokine; Lipid peroxidation; MDA; Oxidative stress; Rolipram

Indexed keywords

BETA ACTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPID; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ROLIPRAM; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BLOOD ANALYSIS; BRUCELLA MELITENSIS; BRUCELLOSIS; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DOMESTIC ANIMAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENETIC TRANSCRIPTION; HOST; INFLAMMATION; INHIBITION KINETICS; LIPID PEROXIDATION; LIVER PARENCHYMA; MACROPHAGE; MALE; NONHUMAN; OXIDATION; PHAGOCYTOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TISSUE SPECIFICITY;

ANIMALS; BRUCELLA MELITENSIS; BRUCELLOSIS; CYCLIC AMP; INTERFERON TYPE II; INTERLEUKIN-10; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROLIPRAM; SPLEEN; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS; RATTUS;

EID: 33846787121     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2006.07.008     Document Type: Article

References (36)

1. Baek B.K., Lee B.O., Hur J., Rahman M.O.S., and Lee S.I. Kakoma I. Evaluation of the Sprague-Dawley rat as a model for vertical transmission of Brucella abortus. Canadian Journal of Veterinary Research 69 (2005) 305-308
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
3. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry 36 (1990) 440-443
4. Erdogan S., and Houslay M.D. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochemical Journal 321 (1997) 165-175
5. Farghali H., Canova N., Gaier N., Lincova D., Kmonickova E., Strestikova P., and Masek K. Inhibition of endotoxemia-induced nitric oxide synthase expression by cyclosporin A enhances hepatocyte injury in rats: amelioration by NO donors. International Immunopharmacology 2 (2002) 117-127
6. Ficht T.A. Intracellular survival of Brucella: defining the link with persistence. Veterinary Microbiology 92 (2003) 213-223
7. Gross A., Bertholet S., Mauel J., and Dornand J. Impairment of Brucella growth in human macrophagic cells that produce nitric oxide. Microbial Pathogenesis 36 (2004) 75-82
8. Gross A., Bouaboula M., Casellas P., Liautard J.P., and Dornand J. Subversion and utilization of the host cell cyclic adenosine 5′-monophosphate/protein kinase A pathway by Brucella during macrophage infection. Journal of Immunology 170 (2003) 5607-5614
9. Harris E.D. Regulation of antioxidant enzymes. The FASEB Journal 6 (1992) 2675-2683
10. Hort G.M., Weisenburger J., Borsdorf B., Peters C., Banai M., Hahn H., Jacob J., and Mielke M.E. Delayed type hypersensitivity-associated disruption of splenic periarteriolar lymphatic sheaths coincides with temporary loss of IFN-gamma production and impaired eradication of bacteria in Brucella abortus-infected mice. Microbes and Infection 5 (2003) 95-106
11. Houslay M.D., Schafer P., and Zhang K.Y. Phosphodiesterase-4 as a therapeutic target. Drug Discovery Today 10 (2005) 1503-1519
12. Jiang X., Leonard B., Benson R., and Baldwin C.L. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cellular Immunology 151 (1993) 309-319
13. Jimenez J.L., Punzon C., Navarro J., Munoz-Fernandez M.A., and Fresno M. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation. The Journal of Pharmacology and Experimental Therapeutics 299 (2001) 753-759
14. Johnson F.J., Reynolds L.J., and Toward T.J. Elastolytic activity and alveolar epithelial type-1 cell damage after chronic LPS inhalation: effects of dexamethasone and rolipram. Toxicology and Applied Pharmacology 207 (2005) 257-265
15. Kariminia A., Kavoossy G., Khatami S., Zowghi E., and Ardestani S.K. Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains. Comparative Immunology, Microbiology and Infectious Diseases 25 (2002) 85-93
16. Kilic N., Ozden M., and Kalkan A. Lipid peroxidation levels in patients with acute brucellosis. Clinical Experimental Medicine 5 (2005) 117-121
17. Kim J.A., Sha Z., and Mayfield J.E. Regulation of Brucella abortus catalase. Infection and Immunity 68 (2000) 3861-3866
18. Koschorreck S., Wenzel F., Fuhrmann M., and Racke K. Effects of phosphodiesterase inhibitors on l-arginine pathways in rat alveolar macrophages. European Journal of Pharmacology 471 (2003) 229-236
19. Kostic M.M., Erdogan S., Rena G., Borchert G., Hoch B., Bartel S., Scotland G., Huston E., Houslay M.D., and Krause E.G. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. Journal of Molecular and Cellular Cardiology 29 (1997) 3135-3146
20. Lopez-Urrutia L., Alonso A., Nieto M.L., Bayon Y., Orduna A., and Sanchez Creapo M. Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages. Infection and Immunity 68 (2000) 1740-1745
21. Lyons C.R., Orloff G.J., and Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. The Journal of Biological Chemistry 267 (1992) 6370-6374
22. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annual Review of Immunology 15 (1997) 323-350
23. Milani E., Nikfar S., Khorasani R., Zamani M.J., and Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comparative Biochemistry and Physiology C, Comparative Pharmacology and Toxicology 140 (2005) 251-255
24. Mohamed H.E., Asker M.E., Ali S.I., and el-Fattah T.M. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. The Journal of Pharmacy and Pharmacology 56 (2004) 757-768
25. Morris D.C., and Ryan J.L. Endotoxins and disease mechanisms. Annual Review of Medicine 38 (1987) 417-432
26. Platzer C., Meisel C., Vogt K., Platzer M., and Volk H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. International Immunology 7 (1995) 517-523
27. Sanz M.J., Cortijo J., and Morcillo E.J. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacology and Therapeutics 106 (2005) 269-297
28. Sugino N., Karube-Harada A., Sakata A., Takiguchi S., and Kato H. Different mechanisms for the induction of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone in human endometrial stromal cells. Human Reproduction 17 (2002) 1709-1714
29. Sun Y., Oberleyi L.W., and Ying L. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34 (1988) 497-500
30. Takano M., Nishimura H., Kimura Y., Washizu J., Mokuno Y., Nimura Y., and Yoshikai Y. Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. Journal of Immunology 161 (1998) 3019-3025
31. Tanuma N., Kojima T., Shin T., Aikawa Y., Kohji T., Ishihara Y., and Matsumoto Y. Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. Journal of Neuroimmunology 73 (1997) 197-206
32. Tatum F.M., Detilleux P.G., Sacks J.M., and Halling S.M. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infection and Immunity 60 (1992) 2863-2869
33. Yoshoiko T., Kawada K., and Shimada T. Lipid peroxidation in maternal and cord blood and protective mechanism against active-oxygen toxicity in the blood. American Journal of Obstetrics and Gynecology 135 (1979) 372-376
34. Young E.J. Human brucellosis. Reviews of Infectious Diseases 5 (1983) 821-842
35. Yumuk Z., Kucukbasmaci O., Buyukbaba Boral O., Kucuker Ang M., and Dundar V. The effects of streptozotocin-induced diabetes on brucellosis of rats. FEMS Immunology and Medical Microbiology 39 (2003) 275-278
36. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., and Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology 42 (2002) 262-269